FIELD: medicine, cardiology, endocrinology, hematology.
SUBSTANCE: the present innovation deals with matching differentiated therapy of thrombopathy in patients with metabolic syndrome. One should detect thrombocyte aggregation index in three transfer tests - collagen, collagen-aspirin and collagen-imidazole. Depending upon the value of collagen test and the ratios of collagen-aspirin and collagen, and, also, collagen-imidazole and collagen tests one should prescribe differentiated therapy. Such therapy deals with hypocaloric diet, dosed physical loading and introduction of metformin at the dosage of 500 mg twice daily at different combinations. Such differentiated approach provides efficient correction of thrombopathy in case of metabolic syndrome.
EFFECT: higher efficiency.
4 ex, 1 tbl
Authors
Dates
2007-10-20—Published
2005-07-25—Filed